Tivozanib Shows Superior Safety Profile Across TKIs in mRCCTivozanibFor the study, researchers conducted a literature review and network meta-analysis of phase 2/3 randomized ...
NICE recommends tivozanib as first-line treatment for advanced renal cell carcinomaNICE| TivozanibEUSA Pharma has announced that the National Institute for Health and Care Excellence (NICE) has published a Final ...
Tivozanib Approved in Europe for Kidney CancerSorafenib| TivozanibThe European Commission (EC) has approved tivozanib (Fotivda) for the treatment of patients with advanced renal ...
EMA Panel Likes Kidney Cancer Drug tivozanibEMA| TivozanibThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ...